Dose Response Trial of Pergolide for Cocaine Dependence - 1

Medical University of South Carolina (MUSC)

Status and phase: Completed; Phase 3

Conditions: Cocaine-Related Disorders

Treatments: Drug: Pergolide

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000248

NIDA-08355-1

R01DA008355 (U.S. NIH Grant/Contract)

R01-08355-1

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.

Sex: All

Ages: 21 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.